Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Myofibroma × Laparoscopy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colonic Neoplasms 7 Stomach Neoplasms 6 Rectal Neoplasms 4 Ovarian Neoplasms 2 Neoplastic Cells, Circulating 2 Neoplasms 2 Gastrointestinal Stromal Tumors 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urinary Incontinence 1 Sexual Dysfunction, Physiological 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Obesity, Morbid 1 Myofibroma 1 Lymphatic Metastasis 1 Locally Advanced Pancreatic Adenocarcinoma 1 Liver Neoplasms 1 Liver Diseases 1 Gynecological Cancer 1 Genital Diseases, Female 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Colorectal Liver Metastasis 1 Cholecystolithiasis 1 Carcinoma, Renal Cell 1

Interventions

Uterine Myomectomy 2 Tourniquets 2 carbetocin 1 Vasopressins 1 Uterine Artery Embolization 1 Triptorelin Pamoate 1 Tranexamic Acid 1 Sevoflurane 1 Saline Solution 1 Respiration, Artificial 1 Remifentanil 1 Propofol 1 Population Groups 1 Nuclear Receptor Subfamily 4, Group A, Member 2 1 Morcellation 1 Methylergonovine 1 Laparoscopy 1 Hysteroscopy 1 Hysterectomy, Vaginal 1 Hysterectomy 1 Ergonovine 1 Dexamethasone 1 Desflurane 1 Buspirone 1 Bupivacaine 1 Ascorbic Acid 1 Anesthesia, Spinal 1 Anesthesia, General 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06067971 2025-09-12

ENDORA2

University Hospital, Clermont-Ferrand

Phase NA Completed

Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡